$1.66
-0.24 (-12.63%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,278.9% upside
Low Target
$19.41
Average Target
$22.89
High Target
$38.59
Current Price
$1.66
Current
$1.66
$1.66
Target
$22.89
$22.89
$19.41
$22.89 avg
$38.59
Scenario Analysis
Bear Case
$19.41
1,069.3%
Low target
Base Case
$22.89
+1,278.9%
Avg target
Bull Case
$38.59
+2,224.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$11.88
-86.0% from high
52-Week Low
$1.78
+-6.7% from low
Target vs 52W High
$22.89
+92.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |